Avalo Therapeutics
AVTX
AVTX
19 hedge funds and large institutions have $28M invested in Avalo Therapeutics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
19
Holding in Top 10
–
Calls
$1K
Puts
$1K
Top Sellers
| 1 | -$40.3K | |
| 2 | -$36.3K | |
| 3 | -$13.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.4K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.38K |